1. Home
  2. Publications
  1. Home
  2. Publications

Filters

Research Groups

Core Facilities

Start date
End date

Comprehensive molecular characterization of mitochondrial genomes in human cancers.
Authors: Y Yuan, YS Ju, Y Kim, J Li, Y Wang, CJ Yoon, Y Yang, I Martincorena, CJ Cre...
Research group: Markowetz Group
E-pub date: 1 Mar 2020
Journal name: Nat Genet

Butler enables rapid cloud-based analysis of thousands of human genomes.
Authors: S Yakneen, SM Waszak, PCAWG Technical Working Group, M Gertz, JO Korbel, ...
Research group: Markowetz Group
E-pub date: 1 Mar 2020
Journal name: Nat Biotechnol

Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Authors: CG Smith, T Moser, F Mouliere, J Field-Rayner, M Eldridge, AL Riediger, D C...
Research group: Bioinformatics,
E-pub date: 28 Feb 2020
Journal name: Genome Med

ThX – a next-generation probe for the early detection of amyloid aggregates.
Authors: L-M Needham, J Weber, JA Varela, JWB Fyfe, DT Do, CK Xu, L Tutton, R Cliffe...
Research group: Bohndiek Group
E-pub date: 21 Feb 2020
Journal name: Chem Sci

AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells.
Authors: J Cidado, S Boiko, T Proia, D Ferguson, SW Criscione, M San Martin, P Pop-D...
Research group: Proteomics
E-pub date: 15 Feb 2020
Journal name: Clin Cancer Res

Abstract P6-04-18: The regulatory role of activating transcription factor-2 (ATF2) in modulating tamoxifen resistance in estrogen-receptor positive breast cancer
Authors: A Giannoudis, MI Malki, H Mohammed, B Rudraraju, S Menon, S Ali, JS Carroll...
Research group: Carroll Group
E-pub date: 15 Feb 2020
Journal name: Cancer Research

Abstract GS2-03: The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer
Authors: E Lim, TA Hickey, LA Selth, KM Chia, HH Milioli, D Roden, G Laven-Law, S Ji...
Research group: Carroll Group
E-pub date: 15 Feb 2020
Journal name: Cancer Research

Abstract P6-05-02: Estrogen receptor beta repurposes EZH2 to inhibit oncogenic NFκB signaling in triple negative breast cancer
Authors: KG Aspros, AW Nelson, Z Ye, Z Sun, I Chernukhin, JS Carroll, JN Ingle, MP G...
Research group: Carroll Group
E-pub date: 15 Feb 2020
Journal name: Cancer Research